Your browser doesn't support javascript.
loading
Integrating proteomics into precision oncology.
Wahjudi, Leonie W; Bernhardt, Stephan; Abnaof, Khalid; Horak, Peter; Kreutzfeldt, Simon; Heining, Christoph; Borgoni, Simone; Becki, Corinna; Berg, Daniela; Richter, Daniela; Hutter, Barbara; Uhrig, Sebastian; Pfütze, Katrin; Leichsenring, Jonas; Glimm, Hanno; Brors, Benedikt; von Kalle, Christof; Stenzinger, Albrecht; Korf, Ulrike; Fröhling, Stefan; Wiemann, Stefan.
Afiliação
  • Wahjudi LW; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bernhardt S; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Abnaof K; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Horak P; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kreutzfeldt S; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Heining C; Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Borgoni S; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Becki C; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden, Dresden, Germany.
  • Berg D; German Cancer Consortium (DKTK), Dresden, Germany.
  • Richter D; Center for Personalized Oncology, National Center for Tumour Diseases (NCT) Dresden and University Hospital Carl Gustav Carus Dresden at TU Dresden, Dresden, Germany.
  • Hutter B; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Uhrig S; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.
  • Pfütze K; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Leichsenring J; Division of Molecular Genome Analysis, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Glimm H; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Dresden, Dresden, Germany.
  • Brors B; German Cancer Consortium (DKTK), Dresden, Germany.
  • von Kalle C; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Stenzinger A; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Korf U; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Fröhling S; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.
  • Wiemann S; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
Int J Cancer ; 148(6): 1438-1451, 2021 03 15.
Article em En | MEDLINE | ID: mdl-32949162
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteômica / Medicina de Precisão / Terapia de Alvo Molecular / Oncologia / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteômica / Medicina de Precisão / Terapia de Alvo Molecular / Oncologia / Neoplasias Tipo de estudo: Guideline / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha